glp-1 and hypothyroidism Patients Who Lose Weight After Starting GLP-1s More Likely to See Thyroid Level Improvement Can a patient with unstable
Description
No worrieswere here to help
Results The first cohort included 36082 GLP-1 receptor agonist users (median follow-up 1.3 years) and 234028 DPP-4 inhibitor users (median follow-up 1.7 years)

GLP-1 (glucagon-like peptide-1) is a natural hormone that helps regulate blood sugar, appetite, and fullness signals, so GLP-1 support products are generally aimed at supporting appetite control, digestion, and weight management habits

In addition, there will be a $350 million up-front payment as Abbvie takes over the reins of GUB-014295 (referred to as Gubamy), a long-acting analog of the satiety hormone amylin, currently in phase I development.
